drugset / Trial / NCT01814917
Long-term Extension Study of MCI-196
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The Primary Objectives of this study are to assess the long-term efficacy of treatment with colestilan (MCI-196) (including combination therapy) and to assess the long-term safety of treatment with colestilan (MCI-196) (including combination therapy).
Timeline
- Start
- 2013-08
- Primary completion
- 2014-12
- Completion
- 2014-12
Outcome
Outcome not reported
Stopped (Enrollment): “This study has been terminated because of insufficient patient recruitment.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | COLESTILAN CHLORIDE | Other / unclassified | 3 g | — |
| Subject | COLESTILAN CHLORIDE | Other / unclassified | 6 g | — |
| Subject | COLESTILAN CHLORIDE | Other / unclassified | 9 g | — |
| Subject | COLESTILAN CHLORIDE | Other / unclassified | 12 g | — |
| Subject | COLESTILAN CHLORIDE | Other / unclassified | 15 g | — |